tiprankstipranks
Trending News
More News >
Outset Medical (OM)
NASDAQ:OM
US Market
Advertisement

Outset Medical (OM) Stock Forecast & Price Target

Compare
371 Followers
See the Price Targets and Ratings of:

OM Analyst Ratings

Moderate Buy
5Ratings
Moderate Buy
3 Buy
2 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Outset
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

OM Stock 12 Month Forecast

Average Price Target

$24.50
▲(39.20%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Outset Medical in the last 3 months. The average price target is $24.50 with a high forecast of $37.00 and a low forecast of $15.00. The average price target represents a 39.20% change from the last price of $17.60.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"8":"$8","20":"$20","32":"$32","44":"$44","56":"$56"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":37,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$37.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[8,20,32,44,56],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2024","6":"Jan<br/>2025","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.73,21.981538461538463,23.233076923076922,24.484615384615385,25.736153846153847,26.987692307692306,28.23923076923077,29.49076923076923,30.74230769230769,31.993846153846153,33.245384615384616,34.496923076923075,35.74846153846154,{"y":37,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.73,21.02,21.31,21.6,21.89,22.18,22.47,22.76,23.05,23.34,23.63,23.92,24.21,{"y":24.5,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,20.73,20.28923076923077,19.84846153846154,19.407692307692308,18.966923076923077,18.526153846153846,18.085384615384616,17.644615384615385,17.203846153846154,16.763076923076923,16.322307692307692,15.881538461538462,15.44076923076923,{"y":15,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.75,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":55.95,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.5,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.48,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.15,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.58,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.92,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.91,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.17,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.81,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.73,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$37.00Average Price Target$24.50Lowest Price Target$15.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on OM
TipRanks AITipRanks
Not Ranked
TipRanks
$17.5
Hold
-0.57%
Downside
Reiterated
07/18/25
Outset Medical's stock score is primarily influenced by its struggling financial performance and unattractive valuation metrics. Despite some positive developments from recent earnings calls and corporate events, the company's ongoing profitability and cash flow issues weigh heavily on its overall evaluation.
RBC Capital
$14$21
Hold
19.32%
Upside
Reiterated
07/15/25
RBC Capital Sticks to Their Hold Rating for Outset Medical (OM)
BTIG
$45$37
Buy
110.23%
Upside
Reiterated
07/14/25
BTIG Reaffirms Their Buy Rating on Outset Medical (OM)
TD Cowen
$15$25
Buy
42.05%
Upside
Reiterated
06/04/25
TD Cowen Sticks to Its Buy Rating for Outset Medical (OM)
Oppenheimer Analyst forecast on OM
Suraj KaliaOppenheimer
Oppenheimer
Hold
Reiterated
05/08/25
Oppenheimer reiterates Perform Rating on Outset Medical Inc. (OM)Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Outset Medical Inc. (NASDAQ: OM).
Stifel Nicolaus Analyst forecast on OM
Rick WiseStifel Nicolaus
Stifel Nicolaus
$15
Buy
-14.77%
Downside
Reiterated
05/08/25
Stifel Nicolaus Keeps Their Buy Rating on Outset Medical (OM)
Morgan Stanley Analyst forecast on OM
Andrew RanieriMorgan Stanley
Morgan Stanley
$67.5$26.25
Hold
49.15%
Upside
Reiterated
08/09/24
Analysts Offer Insights on Healthcare Companies: Outset Medical (NASDAQ: OM), Certara (NASDAQ: CERT) and Harrow Health (NASDAQ: HROW)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on OM
TipRanks AITipRanks
Not Ranked
TipRanks
$17.5
Hold
-0.57%
Downside
Reiterated
07/18/25
Outset Medical's stock score is primarily influenced by its struggling financial performance and unattractive valuation metrics. Despite some positive developments from recent earnings calls and corporate events, the company's ongoing profitability and cash flow issues weigh heavily on its overall evaluation.
RBC Capital
$14$21
Hold
19.32%
Upside
Reiterated
07/15/25
RBC Capital Sticks to Their Hold Rating for Outset Medical (OM)
BTIG
$45$37
Buy
110.23%
Upside
Reiterated
07/14/25
BTIG Reaffirms Their Buy Rating on Outset Medical (OM)
TD Cowen
$15$25
Buy
42.05%
Upside
Reiterated
06/04/25
TD Cowen Sticks to Its Buy Rating for Outset Medical (OM)
Oppenheimer Analyst forecast on OM
Suraj KaliaOppenheimer
Oppenheimer
Hold
Reiterated
05/08/25
Oppenheimer reiterates Perform Rating on Outset Medical Inc. (OM)Oppenheimer analyst Suraj Kalia reiterated a Perform rating on Outset Medical Inc. (NASDAQ: OM).
Stifel Nicolaus Analyst forecast on OM
Rick WiseStifel Nicolaus
Stifel Nicolaus
$15
Buy
-14.77%
Downside
Reiterated
05/08/25
Stifel Nicolaus Keeps Their Buy Rating on Outset Medical (OM)
Morgan Stanley Analyst forecast on OM
Andrew RanieriMorgan Stanley
Morgan Stanley
$67.5$26.25
Hold
49.15%
Upside
Reiterated
08/09/24
Analysts Offer Insights on Healthcare Companies: Outset Medical (NASDAQ: OM), Certara (NASDAQ: CERT) and Harrow Health (NASDAQ: HROW)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Outset Medical

1 Month
xxx
Success Rate
12/18 ratings generated profit
67%
Average Return
+14.08%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 66.67% of your transactions generating a profit, with an average return of +14.08% per trade.
3 Months
xxx
Success Rate
11/21 ratings generated profit
52%
Average Return
+3.79%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 52.38% of your transactions generating a profit, with an average return of +3.79% per trade.
1 Year
Rick WiseStifel Nicolaus
Success Rate
10/21 ratings generated profit
48%
Average Return
-19.01%
reiterated a buy rating 2 months ago
Copying Rick Wise's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of -19.01% per trade.
2 Years
xxx
Success Rate
5/21 ratings generated profit
24%
Average Return
-44.47%
reiterated a xxx
rating 2 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.81% of your transactions generating a profit, with an average return of -44.47% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

OM Analyst Recommendation Trends

Rating
Mar 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
10
7
2
1
2
Buy
2
3
5
4
3
Hold
3
3
4
6
6
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
13
11
11
11
In the current month, OM has received 5 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. OM average Analyst price target in the past 3 months is 24.50.
Each month's total comprises the sum of three months' worth of ratings.

OM Financial Forecast

OM Earnings Forecast

Next quarter’s earnings estimate for OM is -$0.98 with a range of -$1.76 to -$0.64. The previous quarter’s EPS was -$3.24. OM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.07% of the time in the same period. In the last calendar year OM has Preformed in-line its overall industry.
Next quarter’s earnings estimate for OM is -$0.98 with a range of -$1.76 to -$0.64. The previous quarter’s EPS was -$3.24. OM beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.07% of the time in the same period. In the last calendar year OM has Preformed in-line its overall industry.

OM Sales Forecast

Next quarter’s sales forecast for OM is $29.41M with a range of $29.00M to $29.84M. The previous quarter’s sales results were $29.75M. OM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year OM has Preformed in-line its overall industry.
Next quarter’s sales forecast for OM is $29.41M with a range of $29.00M to $29.84M. The previous quarter’s sales results were $29.75M. OM beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.45% of the time in the same period. In the last calendar year OM has Preformed in-line its overall industry.

OM Stock Forecast FAQ

What is OM’s average 12-month price target, according to analysts?
Based on analyst ratings, Outset Medical’s 12-month average price target is 24.50.
    What is OM’s upside potential, based on the analysts’ average price target?
    Outset Medical has 39.20% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is OM a Buy, Sell or Hold?
          Outset Medical has a consensus rating of Moderate Buy which is based on 3 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Outset Medical’s price target?
            The average price target for Outset Medical is 24.50. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $37.00 ,the lowest forecast is $15.00. The average price target represents 39.20% Increase from the current price of $17.6.
              What do analysts say about Outset Medical?
              Outset Medical’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of OM?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis